Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5148-5153

  Rabinovitch, Peter S ^a   Dziadon, Shawna ^a   Brentnall, Teresa A ^a   Emond, Mary J ^a   Crispin, David A ^a   Haggitt, Rodger C ^a   Bronner, Mary P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ANEUPLOIDY; ARTICLE; CANCER RISK; CARCINOGENESIS; CENTROMERE; CHROMOSOME ABERRATION; CHROMOSOME ARM; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECTUM BIOPSY; RISK FACTOR; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

CENTROMERE; CHROMOSOME ABERRATIONS; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 0032695798     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prior, P., Gyde, S. N., Macartney, J. C., Thompson, H., Waterhouse, J. A., and Allan, R. N. Cancer morbidity in ulcerative colitis. Gut, 23: 490-497, 1982.
2. Ekbom, A., Helmick, C., Zack, M., and Adami, H. O. Ulcerative colitis and colorectal cancer: a population-based study. N. Engl. J. Med., 323: 1228-1233, 1990.
3. Collins, R. H., Jr., Feldman, M., and Fordtran, J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N. Engl. J. Med., 26: 1654-1658, 1987.
4. Riddell, R. H., Goldman, H., Ransohoff, D. F., Appelman, H. D., Fenoglio, C. M., Haggitt, R. C., Ahren, C., Correa, P., Hamilton, S. R., Morson, B. C., Sommers, S. C., and Yardley, J. H. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol., 11: 931-968, 1983.
5. Burmer, G. C., Rabinovitch, P. S., Haggitt, R. C., Crispin, D. A., Brentnall, T. A., Kolli, V. R., Stevens, A. C., and Rubin, C. E. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology, 103: 1602-1610, 1992.
6. Brentnall, T. A., Crispin, D. A., Rabinovitch, P. S., Haggitt, R. C., Rubin, C. E., Stevens, A. C., and Burmer, G. C. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology, 2: 369-378, 1994.
7. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instability in colorectal cancers. Nature (Lond.), 6625: 623-627, 1997.
8. Shankey, T. V., Rabinovitch, P. S., Bagwell, B., Bauer, K. D., Duque, R. E., Hedley, D. W., Mayall, B., Wheeless, L., and Cox, C. Guidelines for implementation of clinical DNA cytometry. Cytometry, 14: 472-477, 1993.
9. Rotnitzky, A., and Jewell, N. P. Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika, 77: 485-497, 1990.
10. McCullagh, P., and Nelder, J. A. Generalized Linear Models, 2nd ed., p. 124ff. New York: Chapman and Hall, 1989.
11. Pagano, M., and Gauvreau, K. Principles of Biostatistics. Belmont, CA: Duxbury Press, 1993.
12. Willenbucher, R. F., Zelman, S. J., Ferrell, L. D., Moore, D. H., II, and Waldman, F. M. Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology, 113: 791-801, 1997.
13. Nowell, P. C. Mechanisms of tumor progression. Cancer Res., 46: 2203-2207, 1986.
14. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., SI: 3075-3079, 1991.
15. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instabilities in human cancers. Nature (Lond.), 396: 643-649, 1998.
16. Visscher, D. W., Wallis, T., and Ritchie, C. A. Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis. Cytometry, 21: 95-100, 1995.
17. Buffinton, G. D., and Doe, W. F. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic. Biol. Med., 19: 911-918, 1995.
18. Holmes, E. W., Yong, S. L., Eiznhamer, D., and Keshavarzian, A. Glutathione content of colonie mucosa: evidence of oxidative damage in active ulcerative colitis. Dig. Dis. Sci., 43: 1088-1095, 1998.
19. McKenzie, S. J., Baker, M. S., Buffinton, G. D., and Doe, W. F. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J. Clin. Invest., 98: 136-141, 1996.
20. Lih-Brody, L., Powell, S. R., Collier, K. P., Reddy, G. M., Cerchia, R., Kahn, E., Weissman, G. S., Kalz, S., Floyd, R. A., McKinley, M. J., Fisher, S. E., and Mullin, G. E. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig. Dis. Sei., 41: 2078-2086, 1996.
21. Kinouchi, Y., Hiwatashi, N., Chida, M., Nagashima, F., Takagi, S., Maekawa, H., and Toyota, T. Telomere shortening in the colonie mucosa of patients with ulcerative colitis. J. Gastroenterol., 33: 343-348, 1998.
22. Hande, M. P., Samper, E., Lansdorp, P., and Blasco, M. A. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol., 144: 589-601, 1999.
23. Martens, U. M., Zijlmans, J. M., Poon, S. S., Dragowska, W., Yui, J., Chavez, E. A. Ward, R. K., and Lansdorp, P. M. Short telomeres on human chromosome 17p. Nat. Genet., 18: 76-80, 1998.
24. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature (Lond.), 392: 300-303, 1998.
25. Pihan, G. A., Purohit, A., Wallace, J., Knecht, H., Woda, B., Quesenberry, P., and Doxsey, S. J. Centrosome defects and genetic instability in malignant tumors. Cancer Res., 58: 3974-3985, 1998.